Finland· FI-REL-REL17273
Aurorix
A moclobemide product containing moclobemide, registered in Finland by Paranova Oy. The same ATC class is registered in 12 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Moclobemide is registered in 12 of 19 countries.
Countries holding a registration under ATC N06AG02 (moclobemide), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Moclobemide · ATC N06AG02
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of moclobemide costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $0.54 in France to $1.38 in Switzerland — a ×2.6 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Moclobemide · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.38
- FR France$0.54
The record
At a glance
Fimea (Finland)- Active substance
- Moclobemide
- Manufacturer
- Paranova Oy
- Country
- Finland (FI)
- ATC code
- N06AG02
- ATC class
- Moclobemide
- Defined daily dose
- 0.3 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for moclobemide.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Moclobemide · interactions on record
25 records
25 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Moclobemide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAurorix 300
- CzechiaAURORIXVIATRIS HEALTHCARE LIMITED, Dublin
- NetherlandsMoclobemide Sandoz 300 mg, filmomhulde tablettenSandoz B.V.
- NorwayAurorixViatris AS
- United KingdomManerix 150mg tabletsNecessity Supplies Ltd
- GermanyAurorixViatris Healthcare Gmbh
- CanadaMANERIXBAUSCH HEALTH, CANADA INC.
- SwedenAurorix 150 mg Filmdragerad tablettEbb Medical AB
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Austria · Aurorix
- Belgium · Moclobemide Sandoz
- Czechia · Aurorix
- Germany · Aurorix, Moclobemid 1 A Pharma
- Spain · Manerix
- France · Moclamine
- United Kingdom (Northern Ireland) · Manerix, Moclobemide
- Hungary · Aurorix
- Ireland · Manerix
- Netherlands · Moclobemide Sandoz
- Norway · Aurorix
- Poland · Aurorix, Mobemid
- Portugal · Aurorix, Zorix
- Sweden · Aurorix
- Slovenia · Aurorix
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d604574c-d845-4e8b-a3c6-9e6bc47db92c GET /v1/drugs/d604574c-d845-4e8b-a3c6-9e6bc47db92c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.3",
"form": "tabletti, kalvopäällysteinen",
"route": null,
"ddd_unit": "g",
"strength": "300 mg",
"atc_label": "moklobemidi",
"ma_number": "17284",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL17273",
"authorised_at": "2002-11-21"
}See everything about moclobemide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.